Is it effective to drink four courses of targeted drugs for liver cancer?
The targeted drug had a certain effect on the treatment of liver cancer, but the effectiveness of taking it for four courses varied from person to person. This was related to factors such as the stage of the disease, genetic testing, and the individual's reaction to the drug. If the medicine was used properly, it could effectively prolong the survival period. The effect of targeted therapy in the middle stage of liver cancer was relatively good, and it could usually control the cancer cell migration better. However, targeted therapy was not effective for all patients. Some patients might be able to control their condition after taking targeted drugs, while others might not be effective. At the same time, taking targeted drugs may cause adverse reactions, such as signs and symptoms (rash, hair loss, diarrhea, fatigue, etc.), blood pressure changes (malignant high blood pressure), abnormal tests (abnormal liver function), etc. The severity of adverse reactions will also affect the continuation of treatment. Read more exciting novels for free
What are the targeted drugs for liver cancer?
There were mainly the following types of targeted drugs for liver cancer: 1. Sorafenib (Naxavar), covered by medical insurance for patients with unrespavable or distant cancerous tumors. 2. Lenvatini (Levisma) was indicated for patients with unresectable hepatocelluar cancer who had not received prior systematic therapy. 3. Donafenib tosylate tablets (Zepsen) were indicated for patients with unresected liver cancer who had not received prior systematic treatment. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What medicine is effective in treating liver cancer with targeted therapy?
The following drugs are effective in targeted therapy for liver cancer: 1. Sorafenib: This is a multi-target inhibition drug that suppresses the growth of liver cancer cells and increases their cell death. clinical trials have shown that it can significantly prolong the survival of patients. 2. Rituxan: As a monoclonal-type antibody1, it can bind to the Epidermal Growth Factor1 receptor on the surface of tumor cells and suppress the growth and invasion of liver cancer cells. 3. Oracle Bone Inscription: A kind of human-derived monoclonal-type antibody-specific for liver cancer. By binding to the GCP3 protein on the surface of liver cancer cells, it suppresses the growth and invasion of liver cancer cells. 4. <strong></strong><strong></strong><strong></strong> 5. Regorafenib and lenvatini: targeted drugs for anti-tumor neoplasia. 6. Apatini: It can also be used for targeted therapy of liver cancer. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the effects of taking targeted drugs in the late stage of liver cancer?
There may be the following symptoms when taking targeted drugs for late-stage liver cancer: - If the condition was under control and the tumor growth was suppressed, the tumor might shrink. - For patients with late-stage liver cancer who developed ascitic fluid, if their stomachs gradually subsided after taking the targeted drug, it might mean that the ascitic fluid decreased and the condition was controlled to a certain extent. - The patient's condition was stable. For example, although the tumor did not shrink after taking the targeted drug, its growth rate slowed down. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long will it take for targeted drugs to be effective for lung cancer?
Patients with lung cancer usually took targeted drugs for ten days, no more than forty days, and the effect would take effect in two to three days. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Late stage liver cancer, taking targeted drugs, black stool discharge
There may be many reasons for black stool discharge in patients with late-stage liver cancer when taking targeted drugs. The following is the specific analysis and countermeasures: ##1. Reason Analysis 1. ** Drug factor ** - The targeted drug may cause bleeding in the digestive tract. The hemoglobinin the blood will turn black after digestion in the intestine, resulting in black feces. 2. ** Disease-related factors ** - Patients with late-stage liver cancer may have coagulated due to tumor invasion of the liver, which may lead to digestive tract bleeding. In addition, bleeding from the ruptured esophagus and gastric varices caused by portal vein hypertention was also a common cause. 3. ** Dietary factors ** - Although it is rare, eating too much black food recently (such as mulberries, animal blood products, etc.) may also cause the color of the stool to turn black. ##2. Treatment 1. ** See a doctor immediately ** - After black stool appears, the patient should immediately seek medical attention and describe the symptoms and medication to the doctor in detail. 2. ** Complete relevant checks ** - The doctor may arrange for a stool occult blood test, a colonoscopy, and other examinations to determine if there is any bleeding in the digestive tract and its cause. 3. ** Adjusts treatment plan ** - According to the results of the examination, the doctor may adjust the dose of the targeted drug or change the drug to reduce the risk of digestive tract bleeding. 4. ** Bleeding control treatment ** - If a diagnosis of digestive tract bleeding was confirmed, the doctor might give hemostatic drugs (such as vitamins K1, tranexamic acid, etc.) to promote the synthesis of blood clot factors and reduce bleeding. 5. ** Protect gastric mucus ** - The damaged liver function of patients with late-stage liver cancer may affect the secretion and secretion of bile, causing bile to flow back into the stomach and cause damage to the gastric mucus. At this time, you can use a protective agent for the digestive tract (such as aluminum magnesite, sucralfate, etc.) to neutralize gastric acid and protect the gastric mucus. 6. ** Nutritional support ** - Patients with late-stage liver cancer were usually in poor physical condition, and nutritional supplements (such as compound aa, fat milk, etc.) could provide the necessary nutrients to support the patient's recovery process. 7. ** Pay attention to rest ** - The patient should pay attention to rest and avoid overwork to avoid increasing the burden on the liver. In short, the blackness of patients with late-stage liver cancer during targeted drug therapy was a symptom that needed to be taken seriously. Patients should pay close attention to the changes in their symptoms. If they have persistent black stool or other discomfort symptoms, they should inform the doctor in time. At the same time, they should maintain good eating habits, avoid eating food that may increase the burden on the stomach and intestines, and follow the doctor's advice for treatment and adjustment. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the 32 targeted drugs for treating cancer?
The following are some cancer-targeted drugs: - The targeted drugs for the first-line treatment of lung adenomas and lung cancer with egfr-mutation included osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, bevacidating, and ramulatumab; the second-line treatment (T790M positive) included osimertinib and amitini; the first-line treatment of ALK mutation included alectinib, crizotinib, ceritini, and bugatini; the second-line treatment of crizotinib-resistant included alectinib, bugatinib, and ceritini; and the second-generation targeted drugs included lorlatini. - There were also palinosetron capsules, metoclopramine tablets, ondansetron capsules, and aprepitant capsules. - Larotinib can be used to treat all advanced solid tumors with NtrK gene fusion, including 21 types of cancer, such as thyreoid cancer, myospasm, primary central nervous system tumor, sialoadenoma, Coloembryonic cancer, leukemia, breast cancer, bone sarcomas, histisarcomas, bile duct cancer, hepatic cancer, congenital mesogenic kidney cancer, primary unknown cancer, apexical cancer, liver cancer, bladder cancer, and cervical cancer. However, the number of targeted drugs explicitly mentioned at present did not reach 32, and the complete information of 32 cancer targeted drugs could not be provided. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is the targeted drug for liver cancer metastasizing useful?
If liver cancer patients had metastasized, they could use targeted drugs, but they had to pay attention to their own condition. For patients with liver cancer lung metastasizing, they could take targeted drugs such as sorafenib, gefitini, or afatini. Sorafenib was more commonly used to treat untreatable or distant cancerous tumors. However, if there was severe liver function decline, large amounts of ascitic fluid, digestive tract bleeding, hepatic epilepsy, repeated infection, and other conditions, it was not suitable to use targeted drugs. At the same time, although targeted drugs had a certain effect on many liver cancer patients, some patients had no effect at all, and the cost was relatively high. Therefore, it was necessary to choose according to the individual's actual situation. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it effective to take targeted drugs after draining lung cancer in the late stage? How long is it effective?
For patients with late-stage lung cancer, the effectiveness of targeted drugs was related to many factors. The effectiveness of taking targeted drugs after draining the fluid could not be determined. First of all, an important prerequisite for targeted drugs to work was that genetic testing could find sensitive gene mutation sites. If the patient's genetic test results showed that there was a suitable target, the targeted drug could be effective. There was no direct causality between the operation of draining the fluid from late-stage lung cancer and the effectiveness of the targeted drug. Secondly, the duration of the targeted drug's effect on the patient also varied from person to person. Some patients may see obvious effects at the beginning of the drug, such as tumor shrinking, but due to the possible resistance of cancer cells, the effect may change over time. Some patients may have a good effect at first, but after a period of time (the specific length of time may vary from several months to several years), due to the adaptability of the cancer cells (such as replacing the cell pathway inhibited by the targeted drug through other pathways), the treatment effect will not be ideal. In addition, different types of lung cancer had different responses to targeted drugs. For example, the molecular characteristics of lung cancer were that even if genetic testing was done, common targets were rarely matched. In this case, the targeted drugs might not be effective. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There are several types of breast cancer targeted drugs
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>